Tags

Type your tag names separated by a space and hit enter

The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer.
Am J Med 2017; 130(12):1372-1375AJ

Authors+Show Affiliations

Department of Internal Medicine, Sinai Hospital, Baltimore, Md. Electronic address: madashek@lifebridgehealth.org.Division of Internal Medicine Johns Hopkins University School of Medicine, Baltimore, Md.Department of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Md.Division of Internal Medicine Johns Hopkins University School of Medicine, Baltimore, Md.

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

28882662

Citation

Adashek, Michael L., et al. "The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer." The American Journal of Medicine, vol. 130, no. 12, 2017, pp. 1372-1375.
Adashek ML, Clark BW, Sperati CJ, et al. The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer. Am J Med. 2017;130(12):1372-1375.
Adashek, M. L., Clark, B. W., Sperati, C. J., & Massey, C. J. (2017). The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer. The American Journal of Medicine, 130(12), pp. 1372-1375. doi:10.1016/j.amjmed.2017.08.018.
Adashek ML, et al. The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer. Am J Med. 2017;130(12):1372-1375. PubMed PMID: 28882662.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Hyperlipidemia Effect: Pseudohyponatremia in Pancreatic Cancer. AU - Adashek,Michael L, AU - Clark,Bennett W, AU - Sperati,C John, AU - Massey,Colin J, Y1 - 2017/09/04/ PY - 2017/04/21/received PY - 2017/08/15/revised PY - 2017/08/29/accepted PY - 2017/9/9/pubmed PY - 2018/11/27/medline PY - 2017/9/9/entrez SP - 1372 EP - 1375 JF - The American journal of medicine JO - Am. J. Med. VL - 130 IS - 12 SN - 1555-7162 UR - https://www.unboundmedicine.com/medline/citation/28882662/The_Hyperlipidemia_Effect:_Pseudohyponatremia_in_Pancreatic_Cancer L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9343(17)30896-3 DB - PRIME DP - Unbound Medicine ER -